Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The page removes the Ovarian cancer descriptor and its related topics section, including the MedlinePlus Genetics link, altering how the study's focus and background resources are presented.
    Difference
    0.2%
    Check dated 2026-09-07T21:46:03.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous Revision: v3.6.5, indicating a recent update to the page content or template.
    Difference
    0.1%
    Check dated 2026-08-31T18:12:07.000Z thumbnail image
  4. Check
    21 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, signaling a new build of the page content.
    Difference
    0.1%
    Check dated 2026-08-10T13:28:30.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s revision label updated from v3.6.3 to v3.6.4, indicating a new build behind the page. This is a system-level update rather than a change to the study details or content.
    Difference
    0.1%
    Check dated 2026-07-27T05:39:13.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Ovarian cancer and related topics: MedlinePlus Genetics were added to the glossary/related topics, and the revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T04:41:52.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.2. The related topics block was shortened by removing items such as Ovarian cancer and MedlinePlus Genetics, along with the older Revision: v3.6.0 entry.
    Difference
    0.2%
    Check dated 2026-06-27T23:47:31.000Z thumbnail image

Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.